(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide

C180H221N25O16S4 — CID 160532854

About (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide

(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide (PubChem CID 160532854) has the molecular formula C180H221N25O16S4 and a molecular weight of 3119.17 g/mol. Its IUPAC name is (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide.

Molecular Properties

• Compound Name: (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide
• PubChem CID: 160532854
• Molecular Formula: C180H221N25O16S4
• Molecular Weight: 3119.17 g/mol
• Exact Mass: 3116.61
• IUPAC Name: (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide
• SMILES: CN(C)[C@@H](CCCCNS(=O)(=O)c1ccccc1)C(=O)N[C@@H]1CCc2ccccc2[C@@H]1Cc1cccnc1.CN(C)[C@@H](CCCCNS(=O)(=O)c1ccccc1)C(=O)N[C@H]1CCc2ccccc2[C@H]1Cc1cccnc1.CN(C)[C@H](CCCCNS(=O)(=O)c1ccccc1)C(=O)N[C@@H]1CCc2ccccc2[C@@H]1Cc1cccnc1.CN(C)[C@H](CCCCNS(=O)(=O)c1ccccc1)C(=O)N[C@H]1CCc2ccccc2[C@H]1Cc1cccnc1.COc1ccccc1N1CCN(CC(=O)NC2CCc3ccccc3C2Cc2cccnc2)CC1.O=C(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)NC1CCc2ccccc2C1Cc1cccnc1
• InChI: InChI=1S/C31H35N5O2.4C30H38N4O3S.C29H34N4O2/c37-29(21-35-17-14-31(15-18-35)30(38)33-22-36(31)25-9-2-1-3-10-25)34-28-13-12-24-8-4-5-11-26(24)27(28)19-23-7-6-16-32-20-23;4*1-34(2)29(16-8-9-20-32-38(36,37)25-13-4-3-5-14-25)30(35)33-28-18-17-24-12-6-7-15-26(24)27(28)21-23-11-10-19-31-22-23;1-35-28-11-5-4-10-27(28)33-17-15-32(16-18-33)21-29(34)31-26-13-12-23-8-2-3-9-24(23)25(26)19-22-7-6-14-30-20-22/h1-11,16,20,27-28H,12-15,17-19,21-22H2,(H,33,38)(H,34,37);4*3-7,10-15,19,22,27-29,32H,8-9,16-18,20-21H2,1-2H3,(H,33,35);2-11,14,20,25-26H,12-13,15-19,21H2,1H3,(H,31,34)/t;2*27-,28+,29+;2*27-,28+,29-;/m.1010./s1
• InChIKey: QVTWNKJFHABKNL-FTJBIORUSA-N
• XLogP: 22.61
• TPSA: 500.87 Ų
• H-Bond Donors: 11
• H-Bond Acceptors: 30
• Rotatable Bonds: 61
• Heavy Atoms: 225
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3119.17
LogP ≤ 5	22.61
H-Bond Donors ≤ 5	11
H-Bond Acceptors ≤ 10	30

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide?

The IUPAC name of (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide (CID 160532854) is (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide.

What is the SMILES notation for (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide?

The canonical SMILES for (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide is CN(C)[C@@H](CCCCNS(=O)(=O)c1ccccc1)C(=O)N[C@@H]1CCc2ccccc2[C@@H]1Cc1cccnc1.CN(C)[C@@H](CCCCNS(=O)(=O)c1ccccc1)C(=O)N[C@H]1CCc2ccccc2[C@H]1Cc1cccnc1.CN(C)[C@H](CCCCNS(=O)(=O)c1ccccc1)C(=O)N[C@@H]1CCc2ccccc2[C@@H]1Cc1cccnc1.CN(C)[C@H](CCCCNS(=O)(=O)c1ccccc1)C(=O)N[C@H]1CCc2ccccc2[C@H]1Cc1cccnc1.COc1ccccc1N1CCN(CC(=O)NC2CCc3ccccc3C2Cc2cccnc2)CC1.O=C(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)NC1CCc2ccccc2C1Cc1cccnc1.

What is the InChIKey of (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide?

The InChIKey is QVTWNKJFHABKNL-FTJBIORUSA-N. The full InChI is InChI=1S/C31H35N5O2.4C30H38N4O3S.C29H34N4O2/c37-29(21-35-17-14-31(15-18-35)30(38)33-22-36(31)25-9-2-1-3-10-25)34-28-13-12-24-8-4-5-11-26(24)27(28)19-23-7-6-16-32-20-23;4*1-34(2)29(16-8-9-20-32-38(36,37)25-13-4-3-5-14-25)30(35)33-28-18-17-24-12-6-7-15-26(24)27(28)21-23-11-10-19-31-22-23;1-35-28-11-5-4-10-27(28)33-17-15-32(16-18-33)21-29(34)31-26-13-12-23-8-2-3-9-24(23)25(26)19-22-7-6-14-30-20-22/h1-11,16,20,27-28H,12-15,17-19,21-22H2,(H,33,38)(H,34,37);4*3-7,10-15,19,22,27-29,32H,8-9,16-18,20-21H2,1-2H3,(H,33,35);2-11,14,20,25-26H,12-13,15-19,21H2,1H3,(H,31,34)/t;2*27-,28+,29+;2*27-,28+,29-;/m.1010./s1.

What are the key properties of (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide?

(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide has a molecular weight of 3119.17 g/mol, XLogP of 22.61, 61 rotatable bonds, 11 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for (2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R,2S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2R)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;(2S)-6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S,2R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide is sourced from PubChem (CID 160532854), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).